LND
Brasilagro
3.40$
-1.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
Brasilagro (LND) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,701 million BRL. Tick rows to compare them in a chart.
All figures in millions of BRL.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,463 | 3,282 | 3,341 | 3,605 | 3,855 | 3,940 | 3,972 | 3,837 | 3,826 | 3,735 | 3,821 | 3,701 | |
| 1,268 | 1,110 | 1,220 | 1,099 | 1,155 | 1,094 | 1,252 | 1,178 | 1,188 | 1,075 | 1,200 | 1,090 | |
| 345 | 196 | 201 | 171 | 158 | 28 | 64 | 143 | 219 | 38 | 73 | 168 | |
| 379 | 220 | 226 | 194 | 181 | 48 | 81 | 160 | 236 | 55 | 94 | 185 | |
| 409 | 330 | 362 | 379 | 527 | 426 | 495 | 385 | 374 | 384 | 410 | 328 | |
| 441 | 499 | 533 | 480 | 409 | 580 | 645 | 559 | 532 | 595 | 638 | 562 | |
| 338 | – | – | – | 548 | 562 | 554 | 545 | 536 | 514 | – | – | |
| – | – | – | – | – | – | – | – | 5.0 | 5.2 | – | – | |
| 3.0 | 3.1 | 3.4 | – | 5.0 | 5.4 | 5.3 | 5.1 | 5.0 | 5.2 | 5.2 | 5.0 | |
| 1,212 | 1,306 | 1,384 | 1,425 | 1,585 | 1,737 | 1,802 | 1,659 | 1,722 | 1,657 | 1,780 | 1,679 | |
| 541 | 487 | 597 | 527 | 575 | 647 | 791 | 658 | 711 | 668 | 814 | 706 | |
| 256 | 281 | 340 | 255 | 292 | 305 | 458 | 438 | 507 | 434 | 588 | 558 | |
| 30 | 179 | 220 | 67 | 214 | 201 | 241 | 104 | 134 | 203 | 165 | 65 | |
| 338 | 502 | 501 | 505 | 526 | 566 | 547 | 530 | 523 | 525 | 527 | 549 | |
| 2,251 | 1,976 | 1,957 | 2,180 | 2,270 | 2,203 | 2,170 | 2,178 | 2,103 | 2,078 | 2,041 | 2,022 | |
| 651 | 24 | 359 | 538 | 97 | 78 | 77 | 542 | 478 | -62 | -76 | 409 | |
| 99 | 100 | 100 | 100 | 103 | 103 | 103 | 101 | 100 | 100 | 100 | 100 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.